Shigeaki Suzuki (S Suzuki)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Duchenne Muscular Dystrophy

Myasthenia Gravis

Bone Mineral Density

Top Venues

Annals of clinical and translational neurology

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
Munenori Oyama, Marie-Therese Holzer, Yuko Ohnuki, Yoshihiko Saito, Yukako Nishimori, Shingo Suzuki, Takashi Shiina, Sarah Leonard-Louis, Olivier Benveniste, Udo Schneider, Werner Stenzel, Ichizo Nishino, Shigeaki Suzuki, Akinori Uruha
Pathologic Features of Anti-Ku Myositis. Neurology 102 (8) (2024)
Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Kei Ishizuchi, Daiki Tokuyasu, Hideo Handa, Manato Yasuda, Naoki Kawaguchi, Takashi Kimura, Yasushi Suzuki, Takamichi Sugimoto, Naoya Minami, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurology. Clinical practice 14 (3) (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
Munenori Oyama, Marie-Therese Holzer, Yuko Ohnuki, Yoshihiko Saito, Yukako Nishimori, Shingo Suzuki, Takashi Shiina, Sarah Leonard-Louis, Olivier Benveniste, Udo Schneider, Werner Stenzel, Ichizo Nishino, Shigeaki Suzuki, Akinori Uruha
Pathologic Features of Anti-Ku Myositis. Neurology 102 (8) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology 11 (5) (2024)
Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Kei Ishizuchi, Daiki Tokuyasu, Hideo Handa, Manato Yasuda, Naoki Kawaguchi, Takashi Kimura, Yasushi Suzuki, Takamichi Sugimoto, Naoya Minami, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurology. Clinical practice 14 (3) (2024)
Munenori Oyama, Marie-Therese Holzer, Yuko Ohnuki, Yoshihiko Saito, Yukako Nishimori, Shingo Suzuki, Takashi Shiina, Sarah Leonard-Louis, Olivier Benveniste, Udo Schneider, Werner Stenzel, Ichizo Nishino, Shigeaki Suzuki, Akinori Uruha
Pathologic Features of Anti-Ku Myositis. Neurology 102 (8) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology 11 (5) (2024)
Munenori Oyama, Marie-Therese Holzer, Yuko Ohnuki, Yoshihiko Saito, Yukako Nishimori, Shingo Suzuki, Takashi Shiina, Sarah Leonard-Louis, Olivier Benveniste, Udo Schneider, Werner Stenzel, Ichizo Nishino, Shigeaki Suzuki, Akinori Uruha
Pathologic Features of Anti-Ku Myositis. Neurology 102 (8) (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology 11 (5) (2024)
Daiki Tokuyasu, Shigeaki Suzuki, Akiyuki Uzawa, Yuriko Nagane, Masayuki Masuda, Shingo Konno, Tomoya Kubota, Makoto Samukawa, Takamichi Sugimoto, Kei Ishizuchi, Munenori Oyama, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Yasushi Suzuki, Naoki Kawaguchi, Naoya Minami, Takashi Kimura, Masanori P Takahashi, Hiroyuki Murai, Kimiaki Utsugisawa
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Annals of clinical and translational neurology (2024)
Toshiki Tezuka, Shinichi Okuzumi, Chiho Nakashima, Toshihiro Ide, Shungo Imai, Satoru Mitsuboshi, Yuki Kuwahara, Tsubasa Takizawa, Morinobu Seki, Naoto Minematsu, Naoko Aragane, Jin Nakahara, Satoko Hori, Shunya Nakane, Shigeaki Suzuki
Dysautonomia associated with immune checkpoint inhibitors. Journal of neurology (2023)
Koji Sekiguchi, Kei Ishizuchi, Tsubasa Takizawa, Haruhiko Motegi, Munenori Oyama, Jin Nakahara, Shigeaki Suzuki
Anemia in female patients with myasthenia gravis. PloS one 17 (9) (2022)
Shigeaki Suzuki, Akiyuki Uzawa, Hiroyuki Murai
Efgartigimod for generalized myasthenia gravis with or without anti-acetylcholine receptor antibodies: a worldwide and Japanese perspective. Expert review of clinical immunology 18 (12) (2022)
Yuko Ohnuki, Shigeaki Suzuki, Akinori Uruha, Munenori Oyama, Shingo Suzuki, Jerzy K Kulski, Ichizo Nishino, Takashi Shiina
Association of immune-mediated necrotizing myopathy with HLA polymorphisms. HLA (2022)
Hiroyuki Murai, Shigeaki Suzuki, Miki Hasebe, Yuji Fukamizu, Ema Rodrigues, Kimiaki Utsugisawa
Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance. Therapeutic advances in neurological disorders 14 (2021)
Morinobu Seki, Shigehisa Kitano, Shigeaki Suzuki
Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies. Cancer immunology, immunotherapy : CII (2021)
Shigeaki Suzuki
Significance of Antistriational Antibodies for Immune Checkpoint Inhibitor-Related Myositis: Comment on the Article by Aldrich et al. Arthritis & rheumatology (Hoboken, N.J.) 73 (8) (2021)
Shigeaki Suzuki
Two-year changes of bone mineral density in steroid-treated myasthenia gravis. Journal of bone and mineral metabolism 39 (4) (2021)
Shigeaki Suzuki
Encephalitis as an immune-related adverse event. Journal of neurology, neurosurgery, and psychiatry 91 (7) (2020)
Akiyuki Uzawa, S Kuwabara, Shigeaki Suzuki, T Imai, H Murai, Y Ozawa, M Yasuda, Y Nagane, K Utsugisawa
Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clinical and experimental immunology 203 (3) (2020)
Kensuke Okada, Morinobu Seki, Hiroshi Yaguchi, Kenichi Sakuta, Taiji Mukai, Satoshi Yamada, Koichi Oki, Jin Nakahara, Shigeaki Suzuki
Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature. Journal of neurology 268 (2) (2020)
Munenori Oyama, Kensuke Okada, Masayuki Masuda, Yuko Shimizu, Kazumasa Yokoyama, Akiyuki Uzawa, Naoki Kawaguchi, Ryotaro Ikeguchi, Yasunobu Hoshino, Taku Hatano, Yukiko Ozawa, Jin Nakahara, Hitoshi Aizawa, Kazuo Kitagawa, Nobutaka Hattori, Satoshi Kuwabara, Hiroyuki Murai, Shigeaki Suzuki
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis. Therapeutic advances in neurological disorders 13 (2020)